| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |